(Q46760792)

24 December 2017

title

Protein biomarkers for traumatic and ischemic brain injury: from bench to bedside (English)

1 reference

24 December 2017

1 reference

7

1 reference

24 December 2017

Firas Kobeissy

object named as

Firas Kobeissy

3

0 references

Stefania Mondello

object named as

Stefania Mondello

2

0 references

author name string

Zhiqun Zhang

1

1 reference

24 December 2017

Richard Rubenstein

4

1 reference

24 December 2017

Jackson Streeter

5

1 reference

24 December 2017

Ronald L Hayes

6

1 reference

24 December 2017

publication date

7 December 2011

1 reference

24 December 2017

number of pages

8

1 reference

Translational stroke research

inferred from page(s)

published in

1 reference

24 December 2017

volume

2

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

455-462

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s12975-011-0137-6

exact match

0 references

cites work

Classification of traumatic brain injury for targeted therapies

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Neuroprotection targets after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Biomarkers of blast-induced neurotrauma: profiling molecular and cellular mechanisms of blast brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Proteomic identification of biomarkers of traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Rapid discovery of putative protein biomarkers of traumatic brain injury by SDS-PAGE-capillary liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Use of biomarkers for diagnosis and management of traumatic brain injury patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Novel biomarkers in cardiovascular disease: update 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Application of proteomics technology to the field of neurotrauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Serum biomarker concentrations and outcome after pediatric traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Novel differential neuroproteomics analysis of traumatic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

P43/pro-EMAPII: a potential biomarker for discriminating traumatic versus ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Morphologic and biochemical characterization of brain injury in a model of controlled blast overpressure exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

A panel of neuron-enriched proteins as markers for traumatic brain injury in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Inflammatory mechanisms in ischemic stroke: therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Early Biomarkers of Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Systems biology in neuroscience: bridging genes to cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Structures in systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Clinical trials in head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

The cost of cerebral ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

The development of stroke therapeutics: promising mechanisms and translational challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

How to make better use of thrombolytic therapy in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Blood biomarkers in the diagnosis of ischemic stroke: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Quantitative neuroproteomics of an in vivo rodent model of focal cerebral ischemia/reperfusion injury reveals a temporal regulation of novel pathophysiological molecular markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Serum markers of brain damage and outcome prediction in patients after severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Neuron-specific enolase as an aid to outcome prediction in head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Glial fibrillary acidic protein is highly correlated with brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Proteins released from degenerating neurons are surrogate markers for acute brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Detection of brain injury by fatty acid-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12975-011-0137-6

Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation

21 January 2018

1 reference

12 December 2020

Identification and preliminary characterization of ubiquitin C terminal hydrolase 1 (UCHL1) as a biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Temporal profiles of cytoskeletal protein loss following traumatic axonal injury in mice

1 reference

12 December 2020

Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis

1 reference

12 December 2020

Value of biomarker-based diagnostic test in differential diagnosis of hemorrhagic-ischemic stroke.

1 reference

12 December 2020

Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats

1 reference

12 December 2020

Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury

1 reference

12 December 2020

Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain

1 reference

12 December 2020

Cerebral microdialysis of interleukin (IL)-1beta and IL-6: extraction efficiency and production in the acute phase after severe traumatic brain injury in rats

1 reference

12 December 2020

Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury.

1 reference

12 December 2020

Validation of serum markers for blood-brain barrier disruption in traumatic brain injury

1 reference

12 December 2020

Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury

1 reference

12 December 2020

Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention

1 reference

12 December 2020

Peripheral markers of brain damage and blood-brain barrier dysfunction

1 reference

12 December 2020

Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility

1 reference

12 December 2020

αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients

1 reference

12 December 2020

Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children

1 reference

12 December 2020

Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein

1 reference

12 December 2020

Neurofilament and glial fibrillary acidic protein in multiple sclerosis

1 reference

12 December 2020

Proteomics in neuroscience: from protein to network.

1 reference

12 December 2020

A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels.

1 reference

12 December 2020

Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings

1 reference

12 December 2020

Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury

1 reference

12 December 2020

Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injury

1 reference

12 December 2020

Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients

1 reference

12 December 2020

Alterations of cerebral cortex and hippocampal proteasome subunit expression and function in a traumatic brain injury rat model

1 reference

12 December 2020

10.1007/S12975-011-0137-6

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017